Autoantigenic fragments, methods and assays

Details Autoantigenic fragments, methods and assays Autoantigenic fragments, methods and assays

2005-02-15

2005-02-15

Nolan, Patrick J. (Department: 1644)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Enzymatic production of a protein or polypeptide

Reexamination Certificate

active

06855515

ABSTRACT:
The present invention provides a method of producing autoantigens, compositions comprising autoantigenic fragments and methods of using autoantigenic fragments in the treatment of a condition associated with an autoimmune response. Also provided are assays for the detection or assessment of an autoimmune response.

REFERENCES:
Casciano, et al., “Selective Cleavage of Nuclear Autoantigens During CD95 (Fas/APO-1)-mediated T Cell Apopsotis”, J. Exp. Med., vol. 184, Aug. 1996, pp. 765-770.
Casciano, et al., “Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis”, Molecular Biology Reports, vol. 23, pp. 211-216, 1996.
Rosen, et al, “Macromolecular Substrates for the ICE-Like Proteases During Apoptosis”, Journal of Cellular Biochemistry, vol. 64, pp. 50-54, 1997.
Bach, et al., “New clues to systemic lupus”, Lancet, vol. 350, pp. 11, 1997.
Beidler, et al., “The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis”, J. Biol. Chem., vol. 270, pp. 16526-16528, 1995.
Bockenstedt, et al., “Self-peptides in the initiation of lupus autoimmunity”, J. Immunol., vol. 154, pp. 3516-3524, 1995.
Bump, et al., “Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35”, Science, vol. 269, pp. 1885-1888, 1995.
Burlingame, et al., “Genesis and evolution of antichromatin autoantibodies in muring lupus implicates T-dependent immunization with self-antigen”, J. Clin. Invest., vol. 91, pp. 1687-1696, 1993.
Casciola-Rosen, et al, “Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic kertinocytes”, J. Exp. Med., vol. 179, pp. 1317-1330, 1994.
Casciola-Rosen, et al., “Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death”, J. Biol. Chem., vol. 269, pp. 30757-30760, 1994.
Casciola-Rosen, et al., “DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis”, J. Exp. Med., vol. 182, pp. 1625-1634, 1995.
Casciola-Rosen, et al., “Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principal of apoptotic death”, J. Exp.Med., vol. 183, pp. 1957-1964, 1996.
Casciola-Rosen, et al., “Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in L.E.”, Lupus, vol. 6, pp. 175-180, 1997.
Chinnaiyan, et al., “The Cell-Death Machine”, Curr. Biol., vol. 6, pp. 555-562, 1996.
Chinnaiyan, et al., “Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3”, Curr. Biol., vol. 6, pp. 897-899, 1996.
Darmon, et al., “Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation”, J. Biol. Chem., vol. 271, pp. 21709-21712, 1996.
Darmon, et al., “Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B”, Nature, vol. 377, pp. 446-448, 1995.
Deveraux, et al., “X-linked IAP is a direct inhibitor of cell-death proteases”, Nature, vol. 38, pp. 300-304, 1997.
Diamond, et al., “The role of somatic mutation int he pathogenic anti-DNA response”, Ann. Rev. Immunol., vol. 10, 731-757, 1992.
Duan, et al., “ICE-LAP6, a novel member pf tje ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B”, J. Biol. Chem., vol. 271, pp. 16720-16724.
Fernandes-Alnemri, et al., In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains, Proc. Natl. Acad. USA, vol. 93, pp. 7464-7469, 1996.
Froelich, et al., “Granzyme B perforin-mediated apoptosis of jurkat cells results in cleavage of poly(ADP-ribose)polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment”, Biochem. Biophys. Res. Commun., vol. 227, pp. 658-665. 1996.
Froelich, et al., “New paradigm for lymphocyte granule-mediated cytotoxicity—Target cells bind and internalize granzyme B, but an endosomolytic agent is necessage for cytoxolic delivery and subsequent apoptosis”, J. Biol. Chem., vol. 271, pp. 29073-29079, 1996.
Ghayur, et al., “Proteolytic activation of protein kinase C d by an ICE/CED-3-like protease induces features of apoptosis”, J. Exp. Med., vol. 184, pp. 2399-2404, 1996.
Greidinger, et al., “Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells., ”FEBS Lett., vol. 390, pp. 299-303, 1996.
Gu, et al., Processing and Activation of CMH-1 by Granzyme B., J. Biol. Chem., vol. 271, pp. 10816-10820, 1996.
Heusel, et al., “Cytocoxic lymphocytes require gramzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells”, Cell, vol. 76, pp. 997-987, 1994.
Irmler, et al., Inhibition of death receptor signals by cellular FLIP, Nature, vol. 388, pp. 190-195, 1997.
Jacobson et al., “Programmed cell death in animal development”, Cell, vol. 88, pp. 347-354, 1997.
Jans, et al., “Nuclear transport of granzyme B (fragmentin 2). Dependence on perforin in vivo and cytosolic factors in vitro”, J. Biol. Chem., vol. 271, pp. 30781-30789, 1996.
Krajewska, et al., “Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease”, Cancer Res., vol. 57, pp. 1605-1613, 1997.
Krajewski, et al., “Immunolocalizationo f the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes”, Blood, vol. 89, pp. 3817-3825, 1997.
Lanzavecchia, et al., “How can cryptic epitopes trigger autoimmunity?”, J. Exp. Med., vol. 181, pp. 1945-1948, 1995.
Liu, et al., “DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis”, Cell, vol. 89, pp. 175-184, 1997.
Mamula, et al., “The inability to process a self-peptide allows autoreactive T cells to escape tolerance”, J. Exp. Med., vol. 177, pp. 567-571, 1993.
Martin, et al., “The cytotoxic cell protease gramzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism”, EMBO J., vol. 15, pp. 2407-2416, 1996.
Martin, et al., “Protease activation during apoptosis: Death by a thousand cuts?”, Cell, vol. 82, pp. 349-352, 1995.
McGahon, et al., Regulation of the Fas apoptotic cell death pathway by Abl. J. Biol. Chem., vol. 270, pp. 22625-22631, 1995.
Muzio, et al., “FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex”, Cell, vol. 85, pp. 817-827, 1996.
Nicholson, et al., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature, vol. 376, pp. 37-43, 1995.
Nicholson, et al., “Caspases: Killer proteases”, TIBS, vol. 22, pp. 299-306, 1997.
Odake, et al., “Human and murine cytotoxic T lymphocyte serine proteases: Subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins”, Biochemistry, vol. 30, pp. 2217-2227, 1991.
Pinkoski, et al., “Binding of granzyme B in the nucleus of target cells. Recognition of an 80 kDa protein”, J. Biol. Chem., vol. 271, pp. 10225-10229, 1996.
Podack, et al., “Cytolytic T cell granules. Isolation, structural, biochemical and functional characterization”, J. Med. Exp., vol. 160, pp. 695-710, 1984.
Poe, et al., “Human cytotoxic lymphocute gramzyme B: Its purification from granules and the characterization of substrace

Affiliated with

Also associated with

Rating

Autoantigenic fragments, methods and assays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autoantigenic fragments, methods and assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autoantigenic fragments, methods and assays will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3457044